Kevin L. Bennewith, Ph.D. - Publications

Affiliations: 
2005 University of British Columbia, Vancouver, Vancouver, BC, Canada 
Area:
Medical Biophysics

49 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Arebro J, Lee CM, Bennewith KL, Garnis C. Cancer-Associated Fibroblast Heterogeneity in Malignancy with Focus on Oral Squamous Cell Carcinoma. International Journal of Molecular Sciences. 25. PMID 38279300 DOI: 10.3390/ijms25021300  0.385
2023 Arebro J, Towle R, Lee CM, Bennewith KL, Garnis C. Extracellular vesicles promote activation of pro-inflammatory cancer-associated fibroblasts in oral cancer. Frontiers in Cell and Developmental Biology. 11: 1240159. PMID 37745296 DOI: 10.3389/fcell.2023.1240159  0.311
2023 Sun XX, Nosrati Z, Ko J, Lee CM, Bennewith KL, Bally MB. Induced Vascular Normalization-Can One Force Tumors to Surrender to a Better Microenvironment? Pharmaceutics. 15. PMID 37631236 DOI: 10.3390/pharmaceutics15082022  0.337
2022 Cederberg RA, Franks SE, Wadsworth BJ, So A, Decotret LR, Hall MG, Shi R, Hughes MR, McNagny KM, Bennewith KL. Eosinophils Decrease Pulmonary Metastatic Mammary Tumor Growth. Frontiers in Oncology. 12: 841921. PMID 35756626 DOI: 10.3389/fonc.2022.841921  0.427
2021 Melese ES, Franks E, Cederberg RA, Harbourne BT, Shi R, Wadsworth BJ, Collier JL, Halvorsen EC, Johnson F, Luu J, Oh MH, Lam V, Krystal G, Hoover SB, Raffeld M, ... ... Bennewith KL, et al. CCL5 production in lung cancer cells leads to an altered immune microenvironment and promotes tumor development. Oncoimmunology. 11: 2010905. PMID 35481284 DOI: 10.1080/2162402X.2021.2010905  0.399
2021 Firmino NS, Cederberg RA, Lee CM, Shi R, Wadsworth BJ, Franks SE, Thomas KN, Decotret LR, Bennewith KL. Germinal center hypoxia in tumor-draining lymph nodes negatively regulates tumor-induced humoral immune responses in mouse models of breast cancer. Oncoimmunology. 10: 1959978. PMID 34377597 DOI: 10.1080/2162402X.2021.1959978  0.432
2021 Lebovitz C, Wretham N, Osooly M, Milne K, Dash T, Thornton S, Tessier-Cloutier B, Sathiyaseelan P, Bortnik S, Go NE, Halvorsen E, Cederberg RA, Chow N, Dos Santos N, Bennewith KL, et al. Loss of Parkinson's susceptibility gene LRRK2 promotes carcinogen-induced lung tumorigenesis. Scientific Reports. 11: 2097. PMID 33483550 DOI: 10.1038/s41598-021-81639-0  0.313
2020 Wadsworth BJ, Cederberg RA, Lee CM, Firmino NS, Franks SE, Pan J, Colpo N, Lin KS, Benard F, Bennewith KL. Angiotensin II type 1 receptor blocker telmisartan inhibits the development of transient hypoxia and improves tumour response to radiation. Cancer Letters. PMID 32763272 DOI: 10.1016/J.Canlet.2020.07.015  0.369
2020 Cederberg RA, So A, Franks E, Collier J, Wadsworth BJ, Hughes MR, McNagny KM, Bennewith KL. Abstract A75: The role of eosinophils in the lung tumor microenvironment Cancer Immunology Research. 8. DOI: 10.1158/2326-6074.Tumimm18-A75  0.396
2019 Bosiljcic M, Cederberg RA, Hamilton MJ, LePard NE, Harbourne BT, Collier JL, Halvorsen EC, Shi R, Franks SE, Kim AY, Banáth JP, Hamer M, Rossi FM, Bennewith KL. Targeting myeloid-derived suppressor cells in combination with primary mammary tumor resection reduces metastatic growth in the lungs. Breast Cancer Research : Bcr. 21: 103. PMID 31488209 DOI: 10.1186/S13058-019-1189-X  0.532
2019 Halvorsen EC, Franks SE, Wadsworth BJ, Harbourne BT, Cederberg RA, Steer CA, Martinez-Gonzalez I, Calder J, Lockwood WW, Bennewith KL. IL-33 increases ST2+ Tregs and promotes metastatic tumour growth in the lungs in an amphiregulin-dependent manner. Oncoimmunology. 8. PMID 30713780 DOI: 10.1080/2162402X.2018.1527497  0.382
2019 Decotret L, Bennewith K. TMIC-21. TARGETING INVADOPODIA TO BLOCK IONIZING RADIATION-INDUCED GLIOBLASTOMA CELL INVASION Neuro-Oncology. 21: vi251-vi252. DOI: 10.1093/neuonc/noz175.1055  0.337
2018 Gilabert-Oriol R, Ryan GM, Leung AWY, Firmino NS, Bennewith KL, Bally MB. Liposomal Formulations to Modulate the Tumour Microenvironment and Antitumour Immune Response. International Journal of Molecular Sciences. 19. PMID 30261606 DOI: 10.3390/Ijms19102922  0.389
2018 Martinez VD, Firmino NS, Marshall EA, Ng KW, Wadsworth BJ, Anderson C, Lam WL, Bennewith KL. Non-coding RNAs predict recurrence-free survival of patients with hypoxic tumours. Scientific Reports. 8: 152. PMID 29317756 DOI: 10.1038/S41598-017-18462-Z  0.403
2018 Franks E, Halvorsen EC, Melese E, Arun U, Collier JL, Harbourne BT, Oh MH, Vivian L, Krystal G, English JC, Lam WL, Lam S, Abraham N, Bennewith KL, Lockwood WW. Abstract A02: Oncogenic drivers of lung cancer induce production of CCL5 and recruitment of regulatory T-cells Clinical Cancer Research. 24. DOI: 10.1158/1557-3265.Aacriaslc18-A02  0.461
2017 Marshall EA, Sage AP, Ng KW, Martinez VD, Firmino NS, Bennewith KL, Lam WL. Small non-coding RNA transcriptome of the NCI-60 cell line panel. Scientific Data. 4: 170157. PMID 29064465 DOI: 10.1038/Sdata.2017.157  0.321
2017 Young AGH, Bennewith KL. Ionizing Radiation Enhances Breast Tumor Cell Migration In Vitro. Radiation Research. PMID 28763286 DOI: 10.1667/Rr14738.1  0.453
2017 Swayampakula M, McDonald PC, Vallejo M, Coyaud E, Chafe SC, Westerback A, Venkateswaran G, Shankar J, Gao G, Laurent EMN, Lou Y, Bennewith KL, Supuran CT, Nabi IR, Raught B, et al. The interactome of metabolic enzyme carbonic anhydrase IX reveals novel roles in tumor cell migration and invadopodia/MMP14-mediated invasion. Oncogene. PMID 28692057 DOI: 10.1038/Onc.2017.219  0.401
2017 Dickman CT, Lawson J, Jabalee J, MacLellan SA, LePard NE, Bennewith KL, Garnis C. Selective extracellular vesicle exclusion of miR-142-3p by oral cancer cells promotes both internal and extracellular malignant phenotypes. Oncotarget. PMID 28146434 DOI: 10.18632/Oncotarget.14862  0.332
2016 Nabavi N, Bennewith KL, Churg A, Wang Y, Collins CC, Mutti L. Switching off malignant mesothelioma: exploiting the hypoxic microenvironment. Genes & Cancer. 7: 340-354. PMID 28191281 DOI: 10.18632/Genesandcancer.124  0.414
2016 Marshall EA, Ng KW, Kung SH, Conway EM, Martinez VD, Halvorsen EC, Rowbotham DA, Vucic EA, Plumb AW, Becker-Santos DD, Enfield KS, Kennett JY, Bennewith KL, Lockwood WW, Lam S, et al. Emerging roles of T helper 17 and regulatory T cells in lung cancer progression and metastasis. Molecular Cancer. 15: 67. PMID 27784305 DOI: 10.1186/S12943-016-0551-1  0.475
2016 Halvorsen EC, Hamilton MJ, Young A, Wadsworth BJ, LePard NE, Lee HN, Firmino N, Collier JL, Bennewith KL. Maraviroc decreases CCL8-mediated migration of CCR5(+) regulatory T cells and reduces metastatic tumor growth in the lungs. Oncoimmunology. 5: e1150398. PMID 27471618 DOI: 10.1080/2162402X.2016.1150398  0.502
2016 Takhar MK, Labrecque MP, Tam KJ, Haegert A, Bell RH, Altamirano-Dimas M, Collins CC, Prefontaine GG, Cox ME, Bennewith KL, Beischlag TV. Abstract 2921: The retinoblastoma protein regulates hypoxia-inducible factor-1α-mediated transcriptional programs, tumor cell invasiveness, tumor growth and metastasis in human breast cancer cells Cancer Research. 76: 2921-2921. DOI: 10.1158/1538-7445.Am2016-2921  0.515
2015 Hamilton MJ, Halvorsen EC, LePard NE, Bosiljcic M, Ho VW, Lam V, Banáth J, Bennewith KL, Krystal G. SHIP represses lung inf lammation and inhibits mammary tumor metastasis in BALB/c mice. Oncotarget. PMID 26683227 DOI: 10.18632/Oncotarget.6611  0.503
2015 Conway EM, Pikor LA, Kung SH, Hamilton MJ, Lam S, Lam WL, Bennewith KL. Macrophages, Inflammation, and Lung Cancer. American Journal of Respiratory and Critical Care Medicine. PMID 26583808 DOI: 10.1164/Rccm.201508-1545Ci  0.427
2015 El-Naggar AM, Veinotte CJ, Cheng H, Grunewald TG, Negri GL, Somasekharan SP, Corkery DP, Tirode F, Mathers J, Khan D, Kyle AH, Baker JH, LePard NE, McKinney S, Hajee S, ... ... Bennewith KL, et al. Translational Activation of HIF1α by YB-1 Promotes Sarcoma Metastasis. Cancer Cell. 27: 682-97. PMID 25965573 DOI: 10.1016/J.Ccell.2015.04.003  0.428
2015 Chafe SC, Lou Y, Sceneay J, Vallejo M, Hamilton MJ, McDonald PC, Bennewith KL, Möller A, Dedhar S. Carbonic anhydrase IX promotes myeloid-derived suppressor cell mobilization and establishment of a metastatic niche by stimulating G-CSF production. Cancer Research. 75: 996-1008. PMID 25623234 DOI: 10.1158/0008-5472.Can-14-3000  0.467
2014 Halvorsen EC, Mahmoud SM, Bennewith KL. Emerging roles of regulatory T cells in tumour progression and metastasis. Cancer Metastasis Reviews. 33: 1025-41. PMID 25359584 DOI: 10.1007/S10555-014-9529-X  0.43
2014 Rowbotham DA, Enfield KS, Martinez VD, Thu KL, Vucic EA, Stewart GL, Bennewith KL, Lam WL. Multiple Components of the VHL Tumor Suppressor Complex Are Frequently Affected by DNA Copy Number Loss in Pheochromocytoma. International Journal of Endocrinology. 2014: 546347. PMID 25298778 DOI: 10.1155/2014/546347  0.384
2014 Ho VW, Hamilton MJ, Dang NH, Hsu BE, Adomat HH, Guns ES, Weljie A, Samudio I, Bennewith KL, Krystal G. A low carbohydrate, high protein diet combined with celecoxib markedly reduces metastasis. Carcinogenesis. 35: 2291-9. PMID 25023988 DOI: 10.1093/Carcin/Bgu147  0.363
2014 Hamilton MJ, Bosiljcic M, Lepard NE, Halvorsen EC, Ho VW, Banáth JP, Krystal G, Bennewith KL. Macrophages are more potent immune suppressors ex vivo than immature myeloid-derived suppressor cells induced by metastatic murine mammary carcinomas. Journal of Immunology (Baltimore, Md. : 1950). 192: 512-22. PMID 24285836 DOI: 10.4049/Jimmunol.1300096  0.529
2014 Wilson IM, Vucic EA, Enfield KS, Thu KL, Zhang YA, Chari R, Lockwood WW, Radulovich N, Starczynowski DT, Banáth JP, Zhang M, Pusic A, Fuller M, Lonergan KM, Rowbotham D, ... ... Bennewith KL, et al. EYA4 is inactivated biallelically at a high frequency in sporadic lung cancer and is associated with familial lung cancer risk. Oncogene. 33: 4464-73. PMID 24096489 DOI: 10.1038/Onc.2013.396  0.442
2013 Stratford AL, Berns R, So P, Pambid MR, Abbas F, Abu-Ali S, Hu K, Bennewith K, Dullaghan E, Dunn SE. Abstract B065: The RSK/YB-1 pathway represents an opportunity for targeting TNBC and holds promise of treating metastases Molecular Cancer Research. 11. DOI: 10.1158/1557-3125.Advbc-B065  0.414
2013 Hamilton MJ, Bosiljcic M, LePard NE, Harbourne BT, Krystal G, Bennewith KL. Abstract A108: Distinct immune suppressive myeloid cell populations are induced by hypoxic mammary tumors and differentially promote metastatic tumor growth Molecular Cancer Research. 11. DOI: 10.1158/1557-3125.Advbc-A108  0.573
2013 Hamilton MJ, Bosiljcic M, Harbourne BT, LePard NE, Halvorsen EC, Kim AY, Banath JP, Krystal G, Bennewith KL. Abstract A9: Immune suppressive myeloid cells induced by hypoxic mammary tumor cells persist after primary tumor resection and promote metastatic growth Cancer Research. 73. DOI: 10.1158/1538-7445.Tim2013-A9  0.575
2012 Hamilton MJ, Banáth JP, Lam V, Lepard NE, Krystal G, Bennewith KL. Serum inhibits the immunosuppressive function of myeloid-derived suppressor cells isolated from 4T1 tumor-bearing mice. Cancer Immunology, Immunotherapy : Cii. 61: 643-54. PMID 22021068 DOI: 10.1007/S00262-011-1125-0  0.46
2011 Bennewith KL, Dedhar S. Targeting hypoxic tumour cells to overcome metastasis. Bmc Cancer. 11: 504. PMID 22128892 DOI: 10.1186/1471-2407-11-504  0.428
2011 Bosiljcic M, Hamilton MJ, Banath JP, Lepard NE, McDougal DC, Jia JX, Krystal G, Bennewith KL. Myeloid suppressor cells regulate the lung environment--letter. Cancer Research. 71: 5050-1; author reply. PMID 21750177 DOI: 10.1158/0008-5472.Can-10-3982  0.514
2010 Hamilton MJ, Antignano F, von Rossum A, Boucher JL, Bennewith KL, Krystal G. TLR agonists that induce IFN-beta abrogate resident macrophage suppression of T cells. Journal of Immunology (Baltimore, Md. : 1950). 185: 4545-53. PMID 20844190 DOI: 10.4049/Jimmunol.1002045  0.33
2009 Cairns RA, Bennewith KL, Graves EE, Giaccia AJ, Chang DT, Denko NC. Pharmacologically increased tumor hypoxia can be measured by 18F-Fluoroazomycin arabinoside positron emission tomography and enhances tumor response to hypoxic cytotoxin PR-104. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 15: 7170-4. PMID 19920111 DOI: 10.1158/1078-0432.Ccr-09-1676  0.471
2009 Huang X, Ding L, Bennewith KL, Tong RT, Welford SM, Ang KK, Story M, Le QT, Giaccia AJ. Hypoxia-inducible mir-210 regulates normoxic gene expression involved in tumor initiation. Molecular Cell. 35: 856-67. PMID 19782034 DOI: 10.1016/J.Molcel.2009.09.006  0.385
2009 Bennewith KL, Huang X, Ham CM, Graves EE, Erler JT, Kambham N, Feazell J, Yang GP, Koong A, Giaccia AJ. The role of tumor cell-derived connective tissue growth factor (CTGF/CCN2) in pancreatic tumor growth. Cancer Research. 69: 775-84. PMID 19179545 DOI: 10.1158/0008-5472.Can-08-0987  0.514
2009 Erler JT, Bennewith KL, Cox TR, Lang G, Bird D, Koong A, Le QT, Giaccia AJ. Hypoxia-induced lysyl oxidase is a critical mediator of bone marrow cell recruitment to form the premetastatic niche. Cancer Cell. 15: 35-44. PMID 19111879 DOI: 10.1016/J.Ccr.2008.11.012  0.49
2006 Dornhöfer N, Spong S, Bennewith K, Salim A, Klaus S, Kambham N, Wong C, Kaper F, Sutphin P, Nacamuli R, Nacalumi R, Höckel M, Le Q, Longaker M, Yang G, et al. Connective tissue growth factor-specific monoclonal antibody therapy inhibits pancreatic tumor growth and metastasis. Cancer Research. 66: 5816-27. PMID 16740721 DOI: 10.1158/0008-5472.Can-06-0081  0.496
2006 Erler JT, Bennewith KL, Nicolau M, Dornhöfer N, Kong C, Le QT, Chi JT, Jeffrey SS, Giaccia AJ. Lysyl oxidase is essential for hypoxia-induced metastasis. Nature. 440: 1222-6. PMID 16642001 DOI: 10.1038/Nature04695  0.474
2006 Dornhöfer N, Spong S, Bennewith K, Salim A, Klaus S, Kambham N, Wong C, Kaper F, Sutphin P, Nacamuli R, Höckel M, Le Q, Longaker M, Yang G, Koong A, et al. Erratum: Connective tissue growth factor-specific monoclonal antibody therapy inhibits pancreatic tumor growth and metastasis (Cancer Research (June 1, 2006) 66 (5816-5827)) Cancer Research. 66. DOI: 10.1158/0008-5472.Can-66-15-Cor  0.387
2004 Bennewith KL, Durand RE. Quantifying transient hypoxia in human tumor xenografts by flow cytometry. Cancer Research. 64: 6183-9. PMID 15342403 DOI: 10.1158/0008-5472.Can-04-0289  0.658
2002 Bennewith KL, Raleigh JA, Durand RE. Orally administered pimonidazole to label hypoxic tumor cells. Cancer Research. 62: 6827-30. PMID 12460894  0.628
2001 Bennewith KL, Durand RE. Drug-induced alterations in tumour perfusion yield increases in tumour cell radiosensitivity. British Journal of Cancer. 85: 1577-84. PMID 11720448 DOI: 10.1054/bjoc.2001.2123  0.548
Show low-probability matches.